Our Company
Artemida Pharma is a consultancy firm providing strategic advice and project management for clients looking to develop novel drugs and medical devices. The company was founded in 2014 by Sarah Arbe-Barnes, Robert Miller and David Allman, bringing together a team of consultants with extensive experience in the pharmaceutical industry. Members of the team have been working together for over 20 years initially at Protodigm, a virtual arm within Hoffman-La-Roche, then Fulcrum Pharma Developments and Aptiv Solutions before Artemida Pharma. Each of our consultants has unique insight into the challenges of the drug development process with diverse areas of specialist interest including oncology, autoimmune diseases and infectious disease. Together we have expertise encompassing CMC, pre-/clinical drug development through to regulatory approval and commercial roll-out.
Our aim is to provide independent and pragmatic advice for our clients from biotechnology start-ups to mid-sized pharmaceutical companies. We take pride in building strong relationships and have collaborated with some of our clients for up to 2 decades. We are reactive and responsive to our clients’ needs enabling our clients to develop their products as smoothly as possible.
Queen’s Award for Enterprise
On the 21st April 2018 Her Majesty The Queen announced that Artemida Pharma was to be a recipient of the Queen’s Award for Enterprise in the International Trade Category.
The Queen’s Awards for Enterprise are the UK’s most prestigious business awards, recognising and celebrating business excellence across Great Britain and Northern Ireland. To be considered for the accolade, businesses must have demonstrated outstanding results in their field. Winners are proposed by the Prime Minister, with the aim of inspiring British entrepreneurship and innovation.
This award celebrates Artemida Pharma’s impressive growth and international success.
On the announcement, Founding Partner Dr Sarah Arbe-Barnes reflected:
"To celebrate our 4-year milestone with an award as prestigious as the Queen's Award for Enterprise is a real honour and a testament to how far Artemida has come in such a short period of time driven by the extensive experience of our consultants."
Dr Robert Miller, Chief Medical Officer and Managing Partner, added:
"This award will further encourage us to extend our high standard of expertise in the challenging arena of drug development to our international clients."